. 2021 Jun 13;35(8):e14376. doi: 10.1111/ctr.14376

TABLE 2.

Odds of reporting changes to induction immunosuppression practices by four program‐level factors (significant values in bold)

	T‐cell depleting agents		Non–T‐cell depleting agents		Steroids
	Less likely	More likely	Less likely	More likely	Less likely	More likely
Cumulative COVID‐19 incidence (ref: low) ^a
Medium	_0.72 1.16 _1.85	_0.02 0.20 _1.71	_0.11 0.46 _1.89	_0.51 0.90 _1.57	_0.13 0.92 _6.62	_0.37 0.74 _1.47
High	_0.32 0.55 _0.95	_0.21 0.82 _3.14	_0.14 0.57 _2.35	_0.28 0.55 _1.08	_0.05 0.57 _6.37	_0.23 0.51 _1.17
Baseline transplant volume (ref: low) ^b
Moderate	_1.24 2.19 _3.87	_0.05 0.23 _1.17	_0.19 0.68 _2.41	_1.15 2.35 _4.80	_0.03 0.31 _3.40	_0.57 1.22 _2.61
High	_2.00 3.65 _6.69	_0.09 0.46 _2.35	_0.09 0.47 _2.46	_1.35 2.87 _6.09	_0.14 1.01 _7.27	_0.47 1.10 _2.59
Organ (ref: kidney/pancreas)
Liver	_0.04 0.10 _0.26	0	_0.26 1.05 _4.15	_0.03 0.11 _0.36	_0.38 2.72 _19.58	_0.16 0.42 _1.12
Heart	_0.05 0.15 _0.42	_0.06 0.52 _4.32	_0.08 0.71 _5.91	_0.01 0.07 _0.56	0	_0.09 0.37 _1.61
Lung	_0.00 0.04 _0.27	0	0	_0.01 0.08 _0.59	0	_0.03 0.19 _1.43
Age group (ref: adult or adult/ped)
Pediatric	_0.14 0.34 _0.84	_0.79 3.20 _12.97	_0.09 0.73 _5.78	_0.22 0.56 _1.48	_0.21 1.91 _17.45	_0.08 0.36 _1.51

"Less likely" (/"more likely") indicates that a program reported less likely (more likely) to use the agent in question during the early months of the pandemic, when compared to before the pandemic.

^{^a}

calculated from March 13 to July 15, 2020 as reported by the Johns Hopkins COVID Map, supplemented by covidindia.org. Reported in person per million population (ppm) and divided into tertiles for the entire cohort. Low: <2031 ppm, Medium: 2032‐5400 ppm, High: >5400 ppm

^{^b}

Volume was defined as conducting the following number of transplants/year: Low<20, moderate 20‐100, high >100. "0" with no confidence interval indicates that zero respondents in this category gave this response.